Literature DB >> 31834538

Pituitary neuroendocrine tumors (PitNETs): nomenclature evolution, not clinical revolution.

Sylvia L Asa1, Sofia Asioli2, Suheyla Bozkurt3, Olivera Casar-Borota4, Laura Chinezu5, Nil Comunoglu6, Giulia Cossu7, Michael Cusimano8, Etienne Delgrange9, Peter Earls10, Shereen Ezzat8, Nurperi Gazioglu6, Ashley Grossman11, Federica Guaraldi2, Richard A Hickman12, Hidetoshi Ikeda13, Marie-Lise Jaffrain-Rea14, Niki Karavitaki15, Ivana Kraljević16, Stefano La Rosa7, Emilija Manojlović-Gačić17, Niki Maartens18, Ian E McCutcheon19, Mahmoud Messerer7, Ozgur Mete8, Hiroshi Nishioka20, Buge Oz21, Sara Pakbaz8, Melike Pekmezci22, Arie Perry22, Lilla Reiniger23, Federico Roncaroli24, Wolfgang Saeger25, Figen Söylemezoğlu26, Osamu Tachibana27, Jacqueline Trouillas28, John Turchini29, Silvia Uccella30, Chiara Villa31, Shozo Yamada20, Sema Yarman32.   

Abstract

Entities:  

Year:  2020        PMID： 31834538     DOI： 10.1007/s11102-019-01015-0

Source DB:  PubMed          Journal:  Pituitary        ISSN： 1386-341X            Impact factor:   4.107


× No keyword cloud information.
  7 in total

1.  High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium.

Authors:  Adrian F Daly; Martine Rixhon; Christelle Adam; Anastasia Dempegioti; Maria A Tichomirowa; Albert Beckers
Journal:  J Clin Endocrinol Metab       Date:  2006-09-12       Impact factor: 5.958

2.  From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal.

Authors:  S L Asa; O Casar-Borota; P Chanson; E Delgrange; P Earls; S Ezzat; A Grossman; H Ikeda; N Inoshita; N Karavitaki; M Korbonits; E R Laws; M B Lopes; N Maartens; I E McCutcheon; O Mete; H Nishioka; G Raverot; F Roncaroli; W Saeger; L V Syro; A Vasiljevic; C Villa; A Wierinckx; J Trouillas
Journal:  Endocr Relat Cancer       Date:  2017-04       Impact factor: 5.678

Review 3.  A tale of pituitary adenomas: to NET or not to NET : Pituitary Society position statement.

Authors:  Ken K Y Ho; Maria Fleseriu; John Wass; Aart van der Lely; Ariel Barkan; Andrea Giustina; Felipe F Casanueva; Anthony P Heaney; Nienke Biermasz; Christian Strasburger; Shlomo Melmed
Journal:  Pituitary       Date:  2019-12       Impact factor: 4.107

4.  Outcome of Nonfunctioning Pituitary Adenomas That Regrow After Primary Treatment: A Study From Two Large UK Centers.

Authors:  Metaxia Tampourlou; Georgia Ntali; Shahzada Ahmed; Wiebke Arlt; John Ayuk; James V Byrne; Swarupsinh Chavda; Simon Cudlip; Neil Gittoes; Ashley Grossman; Rosalind Mitchell; Michael W O'Reilly; Alessandro Paluzzi; Andrew Toogood; John A H Wass; Niki Karavitaki
Journal:  J Clin Endocrinol Metab       Date:  2017-06-01       Impact factor: 5.958

5.  Validation of a clinicopathological score for the prediction of post-surgical evolution of pituitary adenoma: retrospective analysis on 566 patients from a tertiary care centre.

Authors:  S Asioli; A Righi; M Iommi; C Baldovini; F Ambrosi; F Guaraldi; M Zoli; D Mazzatenta; M Faustini-Fustini; P Rucci; C Giannini; M P Foschini
Journal:  Eur J Endocrinol       Date:  2019-02-01       Impact factor: 6.664

6.  The incidence rate of pituitary adenomas in western Sweden for the period 2001-2011.

Authors:  Axel Tjörnstrand; Kerstin Gunnarsson; Max Evert; Erik Holmberg; Oskar Ragnarsson; Thord Rosén; Helena Filipsson Nyström
Journal:  Eur J Endocrinol       Date:  2014-08-01       Impact factor: 6.664

7.  A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal.

Authors:  Guido Rindi; David S Klimstra; Behnoush Abedi-Ardekani; Sylvia L Asa; Frederik T Bosman; Elisabeth Brambilla; Klaus J Busam; Ronald R de Krijger; Manfred Dietel; Adel K El-Naggar; Lynnette Fernandez-Cuesta; Günter Klöppel; W Glenn McCluggage; Holger Moch; Hiroko Ohgaki; Emad A Rakha; Nicholas S Reed; Brian A Rous; Hironobu Sasano; Aldo Scarpa; Jean-Yves Scoazec; William D Travis; Giovanni Tallini; Jacqueline Trouillas; J Han van Krieken; Ian A Cree
Journal:  Mod Pathol       Date:  2018-08-23       Impact factor: 7.842
  7 in total
  9 in total

Review 1.  Application of artificial intelligence and radiomics in pituitary neuroendocrine and sellar tumors: a quantitative and qualitative synthesis.

Authors:  Kelvin Koong; Veronica Preda; Anne Jian; Benoit Liquet-Weiland; Antonio Di Ieva
Journal:  Neuroradiology       Date:  2021-11-27       Impact factor: 2.804

2.  Multiple tumorous lesions of the pituitary gland.

Authors:  Jannik von Schöning; Jörg Flitsch; Dieter K Lüdecke; Rudolf Fahlbusch; Michael Buchfelder; Rolf Buslei; Ulrich J Knappe; Markus Bergmann; Walter J Schulz-Schaeffer; Jochen Herms; Markus Glatzel; Wolfgang Saeger
Journal:  Hormones (Athens)       Date:  2022-08-10       Impact factor: 3.419

Review 3.  High-risk pituitary adenomas and strategies for predicting response to treatment.

Authors:  George Kontogeorgos; Eleni Thodou; Robert Y Osamura; Ricardo V Lloyd
Journal:  Hormones (Athens)       Date:  2022-01-21       Impact factor: 2.885

4.  Pituitary Neoplasm Nomenclature Workshop: Does Adenoma Stand the Test of Time?

Authors:  Ken Ho; Maria Fleseriu; Ursula Kaiser; Roberto Salvatori; Thierry Brue; M Beatriz Lopes; Pamela Kunz; Mark Molitch; Sally A Camper; Mônica Gadelha; Luis V Syro; Edward Laws; Martin Reincke; Hiroshi Nishioka; Ashley Grossman; Ariel Barkan; Felipe Casanueva; John Wass; Adam Mamelak; Laurence Katznelson; Aart J van der Lely; Sally Radovick; Martin Bidlingmaier; Margaret Boguszewski; Jens Bollerslev; Andrew R Hoffman; Nelson Oyesiku; Gerald Raverot; Anat Ben-Shlomo; Rob Fowkes; Ilan Shimon; Hidenori Fukuoka; Alberto M Pereira; Yona Greenman; Anthony P Heaney; Mark Gurnell; Gudmundur Johannsson; Robert Y Osamura; Michael Buchfelder; Maria Chiara Zatelli; Marta Korbonits; Philippe Chanson; Nienke Biermasz; David R Clemmons; Niki Karavitaki; Marcello D Bronstein; Peter Trainer; Shlomo Melmed
Journal:  J Endocr Soc       Date:  2021-02-09

Review 5.  GH and IGF System: The Regulatory Role of miRNAs and lncRNAs in Cancer.

Authors:  Cecilia Catellani; Gloria Ravegnini; Chiara Sartori; Sabrina Angelini; Maria E Street
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-16       Impact factor: 5.555

6.  Gonadotroph tumours with a low SF-1 labelling index are more likely to recur and are associated with enrichment of the PI3K-AKT pathway.

Authors:  Richard A Hickman; Jeffrey N Bruce; Marc Otten; Alexander G Khandji; Xena E Flowers; Markus Siegelin; Beatriz Lopes; Phyllis L Faust; Pamela U Freda
Journal:  Neuropathol Appl Neurobiol       Date:  2020-12-20       Impact factor: 8.090

Review 7.  Classification of neuroendocrine neoplasms: lights and shadows.

Authors:  Stefano La Rosa; Silvia Uccella
Journal:  Rev Endocr Metab Disord       Date:  2020-11-09       Impact factor: 9.306

Review 8.  Novel Insights into Pituitary Tumorigenesis: Genetic and Epigenetic Mechanisms.

Authors:  Vinaya Srirangam Nadhamuni; Márta Korbonits
Journal:  Endocr Rev       Date:  2020-12-01       Impact factor: 19.871

Review 9.  Genetics of Acromegaly and Gigantism.

Authors:  Anna Bogusławska; Márta Korbonits
Journal:  J Clin Med       Date:  2021-03-29       Impact factor: 4.241
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.